Related Experiment Video
Updated: Aug 14, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Case-control analysis of the financial cost of medication errors in hospitalized patients
Jaime Pinilla1, Carles Murillo, Genís Carrasco
1University of Las Palmas de Gran Canaria, Spain. jpinilla@dmc.ulpgc.es
Abstract:
The cost of medication errors (MEs), and by extension their impact on the running of hospitals, is generally unknown to hospital managers. This study estimated the financial costs involved in the additional use of hospital resources as a result of MEs. For this we used a database covering 20,014 hospital admissions, with clinical and personal information about each patient, the costs related to his/her stay, and physicians' prescriptions. Analyses were carried out using cases and control techniques to calculate the additional cost of MEs. During the study period, 2001, the analysis indicated that the MEs analyzed caused an additional 303 days of hospital stay, with an overall annual cost of nearly 6,000 euros. Our study confirms that MEs are a costly reality. The presence of MEs doubled the cost per patient.
Related Concept Videos
Errors occurring during blood pressure monitoring
Several factors...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic illness...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Pharmaceutical Poisoning: Potential Scenarios
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Guidelines and Strategies for Safe Computer Charting
Maintain Confidentiality and Security: